The year ended with the capital markets faltering and an erosion of our share price. To preserve our capital, we took immediate action in early 2019 and implemented a reduction in expenditures. Cost reduction steps included:•Suspension of Directors fees•Suspension of instrument development costs•Re-organization and reduction in staff and consultants•Other general reduction in expenses and travel restrictions
- Forums
- ASX - By Stock
- IBX
- Ann: FDA Breakthrough Device Designation
Ann: FDA Breakthrough Device Designation, page-193
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.5¢ |
Change
-0.001(1.16%) |
Mkt cap ! $2.775M |
Open | High | Low | Value | Volume |
8.6¢ | 8.6¢ | 8.5¢ | $1.627K | 19.08K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 53 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 3376 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 53 | 0.085 |
3 | 12818 | 0.080 |
1 | 18729 | 0.077 |
1 | 13155 | 0.076 |
2 | 32500 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 3376 | 1 |
0.088 | 4862 | 1 |
0.089 | 295 | 1 |
0.090 | 1479 | 2 |
0.093 | 1500 | 1 |
Last trade - 13.13pm 24/06/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |